Summary.-One hundred and nineteen specimens of human mammary tissue taken from 112 individuals, were inspected by pulsed proton magnetic-resonance techniques (at 22-5 MHz). The purpose of the study was to evaluate the diagnostic capabilities of the nuclear magnetic resonance (NMR) technique with regard to the recognition of malignancy. The combination of two NMR parameters (spin lattice (T1) and spin-spin(T2) relaxation times) into a malignancy index produced better than 950o/ discrimination between the 2 populations of tissue on a case-by-case basis. The mean and standard deviations obtained were 2-002±0-351 for normal tissue, and 3 137±0 667 for malignant specimens. The probability that this difference is not significant is considerably less than 0-01. In addition, specimens of fibrocystic disease and fibrous mastopathy had indices of 2.263±0-503 and 2 151±0-505 respectively. Both groups yielded P values less than 0-01 when compared to the malignant specimens.
A NUMBER of previous nuclear magneticresonance (NMR) investigations of human mammary tissues have been published (Damadian et al., 1973; Schmidt et al., 1973; Eggleston et al., 1975; Medina et al., 1975; Ranade et al., 1976; Beall et al., 1976) . All these studies except that of Medina et al. (1975) were limited, in the respect that the spin-lattice relaxation time (T1) was the only NMR parameter determined.
The purpose of this study was 2-fold. First, we wished to measure NMR parameters other than T1, with the aim of combining them for diagnostic purposes into a malignancy index which could more reliably discriminate normal tissue from malignant tissue. Second, we wished to extend our earlier results at 100 MHz (Damadian et al., 1973 ) to a larger sample population, in order to define the confidence limits of the technique for diagnosis.
MATERIALS AND METHODS
Autopsy material was obtained from the morgue at the Kings County Medical Examiner's Office. Samples were taken within 24 h of death, primarily from individuals who died from accidents. The other tissue specimens were mainly obtained at the surgical pathology laboratory of Sloan-Kettering Memorial Hospital, within hours of surgery. A small number of samples (10%) was also obtained from the surgical pathology sections at Methodist Hospital, as well as the State University Hospital at this institution. This study included a total of 119 samples of human mammary tissue taken from 112 different individuals. The pathologists who supplied the specimens did not have a definitive diagnosis at the time we obtained them. In the majority of cases, the technician doing the NMR analysis did not even know the organ from which a particular sample originated, so that this investigation was essentially double-blind in character.
Upon receipt of the specimens, a technician would place them in an airtight test tube on ice, and bring them to this laboratory. At this laboratory, a second technician would prepare a portion of the specimen for NMR analysis and, after trimming it of fat and connective tissue, place it in a 5 mm NMR tube, so that it formed a column 4 mm high after being gently tamped down. The NMR tubes used had both ends open in order to make the removal of tissue for microscopic analysis easier. The top of the NMR tube was capped, and the bottom was sealed with a friction-fitting Teflon plug, before the sample was run in the NMR. Occasionally, tissue adjacent to that used for the NMR analysis was apportioned for chemical analysis. Wherever possible, all 4 NMR parameters were determined on each sample, although time limitations would occasionally force the elimination of a particular measurement. Similarly, whereever possible, we restricted chemical analysis to tissues which had also undergone NMR investigation.
When the NMR analysis had been completed, the sample was removed from the NMR tube and placed in a tissue cassette in a bath of 10% formalin. At the end of the work day, the tissue cassettes were brought to the pathology laboratory at this institution, where the samples were prepared for microscopic analysis. Simultaneously, the raw data from the NMR analysis were given to a third technician. In about 70% of the cases studied, the 3 technicians referred to were 3 different individuals. In about 20% of the cases, a single individual had all 3 roles. This 20% of the study was not "double blind" in character, and has been considered separately under the label of an "intensive study" . This individual then graphed the data, calculated the various NMR parameters and recorded the final values in a hardbound notebook. A similar procedure was followed with the chemical data when it became available. The microscope slides prepared for each sample were given to a pathologist for his diagnosis. Originally, 5 slides were prepared from each tissue block, but this was later reduced to a single slide, to reduce unnecessary replication of labour. The pathologist's report became available about one month after the NMR analysis. At this time, the final patient diagnosis was also available from the hospital where the tissue originated.
As the final data reduction for the study took place, we felt a need for a more detailed histological description of each sample run in the NMR. A second pathologist was requested to give his diagnosis for each slide, as well as an estimation of the percentage of the microscopic field that contained fat, fibrous tissue, or normal parenchyma as well as that percentage of the sample which was composed of malignant cells. Thus, 2 separate diagnoses from 2 different pathologists were available for most samples.
The methods used in the NMR measurements themselves and in the chemical analyses were identical to the methods described in detail elsewhere (Goldsmith et at., 1977a; .
RESULTS
In addition to normal breast tissue obtained at autopsy, and malignant tumours obtained at surgery, we examined a large number of specimens (obtained at surgery) which were classified as fibrous mastopathy or fibrocystic disease. In all cases, these benign conditions were coincident with malignancy.
Unlike most other human tissues, virtually all specimens of mammary tissue exhibit a clear 2-fraction behaviour in their T1 plots. The proportion of fastrelaxing material could be related to the amount of fat seen microscopically in the specimen slides, although the occasional presence of large quantities of fibrous tissue complicate this relation. These findings are consistent with the results of Hazlewood et al. (1972) who observed the presence of a lipid peak in the highresolution spectra of protons in murine mammary tissue. Under these conditions, the null T1 measurement will merely represent the weighted average value for the T1 of the various relaxing fractions. However, deconvolution of the complete biphasic T1 decay curve may be done by fitting the data to a sum of 2 exponentials in a nonlinear regression analysis. Such computer analyses were done on all breast samples and allowed us to compute a separate T1 value for the slow-relaxing fraction alone (Tl). The results of this Tl determination are indicated in Fig. 1 . The upper level of the graph indicates the distribution of values for normal and malignant specimens. The lower level of the graph indicates the distribution for samples exhibiting fibrous mastopathy or fibrocystic disease. Fig. 2 Eggleston et al. (1975 Medina et al. (1975) . All values in milliseconds. Table II . Here a cut-off value of 2-500, produces 100% separation between the normal and cancer populations. More impressively, 100% of the cancers have indices more than 2 standard deviations from the mean of the normal population. Thus, our results and those of Medina et al. agree very well.
The results of this study may also be directly compared to those of a smaller study at a similar frequency (24 MHz) (Eggleston et al., 1975) . The comparison is made in the histograms in Fig. 4 . The data in the upper portion of the figure is that presented above; that in the lower portion is from the paper of Eggleston et al. (1975) . It is clear that the results of both groups with regard to the distributions of null T1 among the various categories of tissue also agree quite well. Unfortunately, the other NMR parameters were not determined in that study, so that a test of the Malignancy Index with respect to their data is not possible. From the null T1 data in Fig. 4 , Eggleston et al. drew the conclusion that NMR is unable to distinguish cancer from benign pathological states. We believe that this conclusion, as it is based only on the null T1 measurements on relatively few samples, is not justified. This is true especially in the absence of enough data to compute a "malignancy index". On the contrary, we believe that our preliminary evidence indicates that, at the very least, a significant proportion of benign pathologies may be distinguished from malignancy by NTMR techniques.
To clarify this point further, we note that the use of the Malignancy Index yields P values (the probability that the difference between means arises by chance) less than 0X01 for either category of benign pathology given in Table I when they are compared to the cancer group. This is true despite the fact that these benign pathologies came from patients with cancer, a situation which might give high values to histologically normal tissue (Frey et al., 1972; Koutcher et al., 1977; Goldsmith et al., 1978; Fruchter et al., 1978) . In addition, the earlier results of Medina et al. (1975) demonstrated that, although fibroadenomas could not be immediately distinguished from cancer, fibrocystic disease gave relaxation values not significantly different from normal tissue. Indeed, Table II shows that only one of his specimens out of 21 has a malignancy index clearly in the cancer region. It remains to be seen whether these overlap cases can be correlated with premalignant conditions, or if indeed a more careful study of benign pathologies might relate them to the fact that the patients involved also hosted a nearby malignancy.
Part of the pessimism of the Eggleston group stems from the inclination to assume that superficially "wet" benign states, such as inflammation, will interfere with the cancer-diagnostic abilities of NMR. This is shown by the statement (Eggleston et al., 1975) "that prolongation of the spin-lattice relaxation time is largely the result of increased water content of the tissue examined . . .". However, this group offered no experimental measurements on the tissues they studied to support this conclusion.
Indeed, we find the relationship between the tissue relaxation times and the tissue water content to be as yet unclear. For example, we were able to relate these 2 variables in colon specimens and they did not show a relationship in lung specimens (Goldsmith et al., 1977a affect the relaxation times of biological specimens. Table III is a brief summary of measurements we made on adipose tissue taken from female breast specimens and on lobular breast specimens dissected free of fat. The adipose tissue (top row) has one order of magnitude less water than the breast tissue (bottom row); however, the relative changes in T1 and T2 values are in opposite directions. In general, we have consistently found that the presence of fat in a sample lowers T1, but raises T2. Thus, the dependence of the relaxation times T1 and T2 in these tissues are hardly predictable from water content alone. Especially in breast tissue, with its highly variable fat content, these results demand more than a priori assumptions about the effects of water on samiple relaxation times.
Certainly, the ability of NMR to distinguish benign pathology from cancer does require further investigation, with special care taken to obtain specimens from cancer-free patients. The recent NMR imaging of the live human chest Minkoff et al., 1977; Goldsmith et al., 1977b) gives some hope that these questions can be answered by application of in vivo NMR methodology. In any case, we believe that the benign vs malignant question is the next appropriate problem, in that the results of the present investigation firmly demonstrate that a clear distinction can be made between normal and malignant specimens.
